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ABSTRACT
Background  Lymphoedema is a distressing 
problem affecting many women after breast cancer 
surgery. There is no cure and existing treatments are 
marginally beneﬁ  cial, rarely reducing arm swelling in 
any meaningful way. Needling and even lifting of 
objects using the affected arm has been prohibited, 
but our clinical experience and that of others 
suggested that acupuncture was safe and that it 
might be a useful treatment for lymphoedema.
Objective  We sought to conduct a pilot study of 
the safety and effectiveness of acupuncture in 
women diagnosed with chronic lymphoedema for at 
least 6 months and less than 5 years.
Methods  Women with chronic lymphoedema 
(affected arm with >2 cm circumference than 
unaffected arm) after breast cancer surgery received 
acupuncture twice a week for 4 weeks. Response 
was deﬁ  ned as at least a 30% reduction in the 
difference in size between the affected and 
unaffected arms. Monthly follow-up calls for 6 
months following treatment were made to obtain 
information about side effects.
Results  Study goals were met after nine subjects 
were treated: four women showed at least a 30% 
reduction in the extent of lymphoedema at 4 weeks 
when compared with their respective baseline 
values. No serious adverse events occurred during 
or after 73 treatment sessions.
Limitations  This pilot study requires a larger, 
randomised follow-up investigation plus enquiries 
into possible mechanisms. Both are in development 
by our group.
Conclusion  Acupuncture appears safe and may 
reduce lymphoedema associated with breast cancer 
surgery.
BACKGROUND
A primary cause of lymphoedema, or swelling 
of a limb, is surgery or radiation treatment for 
breast cancer. The accumulation of ﬂ  uid occurs 
when lymph nodes are removed. In a study of 
251 women who had surgical treatment for 
breast cancer involving sampling, excision or 
biopsy of axillary nodes, 39 (20.7%) had devel-
oped lymphoedema at 3 years postsurgery. 
Risk factors for development of lymphoedema 
in this study included mastectomy and body 
mass index ≥26.1 Lymphoedema is considered 
a chronic, life-long condition as there are no 
curative treatments.2 While uncommon when 
axillary surgery is restricted to sentinel lymph 
node biopsy (6.9% of patients),3 a study of 109 
patients with mild lymphoedema found that 
the unpredictable rate of progression from 
mild to more severe lymphoedema was 79% 
at 1 year, 66% at 3 years and 52% at 5 years.4
Physical problems and emotional distress 
are commonly reported by breast cancer survi-
vors with lymphoedema. Impaired quality of 
life, limitations to daily activities, the constant 
protection required to avoid activities feared 
to exacerbate or cause lymphoedema, and 
the body image issues associated with hav-
ing one abnormally enlarged limb are reported 
in numerous publications.5–14 A study of the 
economic burden of breast cancer-related lym-
phoedema includes greater risk of infections 
and higher medical costs.15
Little research has been published on acu-
puncture for lymphoedema. In the USA, 
this is due in large part to the prohibition 
against needling and to other efforts to pro-
tect the affected arm. However, studies from 
Japan and USA on acupuncture for lymphoe-
dema found neither infection nor other side 
effects.16 17 Acupuncture is a safe treatment 
when performed by qualiﬁ  ed  practitioners. 
After 760  000 treatments in 97  733 patients 
receiving acupuncture in Germany, only six 
cases of serious adverse events (SAEs) were 
reported.18 In another study from Germany, 
229 230 patients received over 2.2 million acu-
puncture sessions. Adverse effects occurred in 
8.6% of the sampled patients, however, most 
were minor events such as bleeding and bruis-
ing. Of all adverse effects, 0.1% was indica-
tive of negligence or malpractice (broken or 
forgotten needle, pneumothorax, burns after 
moxibustion).19
This study sought to obtain preliminary evi-
dence of the effects of acupuncture on chronic 
lymphoedema due to breast cancer treatment 
and to further evaluate the safety of acupunc-
ture in this setting.
METHODS
After approval of the protocol by the institu-
tional review board, patients were identiﬁ  ed 
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and screened by an Integrative Medicine Service research 
assistant. After obtaining informed consent and following 
approval from the beast cancer physicians at the Memorial 
Sloan-Kettering Cancer Center (MSKCC), patients were 
accrued to the study. Inclusion criteria were women aged 
18 years or older; lymphoedema in an arm as a result of 
surgery and/or radiation therapy for breast cancer; clinical 
diagnosis of lymphoedema for at least 6 months and no 
more than 5 years; and affected arm with >2 cm circum-
ference than the unaffected arm. Previous acupuncture 
treatment for lymphoedema and the current use of diuret-
ics were the sole exclusion criteria.
Upper extremity measurements were performed in a 
standard fashion: the circumference of the patient’s upper 
arms and forearms was measured, in both the affected 
and unaffected limbs, before and after each treatment. 
The upper arm was measured at 10 cm above the olecra-
non process; the forearm was measured at 5 cm below 
the olecranon process. The site with the greater difference 
between affected and unaffected arms (either the forearm 
or the upper arm) was used to determine baseline and 
outcome assessment for each patient. Changes in each 
Table 1 Acupoint  prescription
Points Location
LI15 Anteroinferior to the acromion, on the upper portion of musculus 
deltoidus
LI4 On dorsum of the hand, midpoint of the second metacarpal bone, 
in the belly of the ﬁ  rst interosseus dorsalis muscle
TE14 Posterior and inferior to the acromion
CV12 Midline of the abdomen, midpoint between umbilicus and xiphoid 
process
CV3 Midline of the abdomen, four inches below umbilicus
LU5 On the cubital crease, radial side of the tendon of musculus biceps 
brachii
SP6 Posterior border of the medial aspect of the tibia, three inches 
above the tip of the malleolus
ST36 Lateral to the tibia’s anterior crest, inferior to the lateral side of the 
patella
Needles were retained for 30 min.
patient’s arm circumference were compared against her 
baseline measures.
Response was deﬁ  ned as at least a 30% reduction in 
the difference in size between the affected and unaffected 
arms after 4 weeks of treatment.
Traditional Chinese Medicine acupuncture treatment 
was given by certiﬁ   ed acupuncturist members of the 
MSKCC Integrative Medicine Service. All Integrative 
Medicine Service acupuncturists are licensed, credentialed 
employees of MSKCC. They selected the point prescrip-
tion by consensus, based on historical context plus their 
relevant professional experience. The same point prescrip-
tion was used for all patients; needle stimulation was a 
manual gentle rotation with lift and thrust. Needles were 
inserted bilaterally, in the affected as well as the unaf-
fected limb. The acupuncturists were not intentionally 
seeking de qi sensation.
Alcohol swabs were applied prior to insertion of sterile, 
ﬁ  liform, single-use needles (Tai Chi Brand, 32-36 gauge, 
1 or 1.5 inch needles; made in China and distributed by 
Lhasa OMS, Weymouth, Massachusetts, USA) that pen-
etrate 5–10 mm into the skin. The acupoint prescription 
is given in Table 1.
Study patients received acupuncture twice a week for 
4 consecutive weeks at the MSKCC Integrative Medicine 
Outpatient Center. Thereafter, patients were asked to 
contact the research assistant should any side effects 
occur, and monthly follow-up calls were made to study 
the subjects for 6 months to obtain information about any 
side effects.
The study design was a Simon’s two-stage minimax 
design with a null and alternative hypotheses of 5% and 
20%, respectively. We planned to enroll 13 patients in the 
ﬁ  rst stage of the study; if there was at least one response, 
we planned to accrue an additional 14 patients, declaring 
acupuncture worthy of further study if a total of four or 
more responses occurred in the total of 27 patients.
RESULTS
The trial was stopped early when four responses were 
obtained. Eleven patients had been enrolled. Two with-
drew due to time constraints. The nine participants 
Table 2  Study patients’ demographic and clinical data (the ﬁ  rst four patients are the responders)
Patient 
number Age
Race/
ethnicity Surgery RT Chemo
Affected 
limb
Years since 
lymphoedema Dx
BMI at 
baseline (lbs)
Baseline 
difference (cm)
Post-Tx 
difference (cm) Responder
1 56 W Lump Y Y Left 2.3 43.1 2.2 0.9 Y
2 51 A Mast Y Y Left 2.6 26.7 2.1 0.4 Y
3 54 B Mast N Y Left 1.7 23.5 2.0 0.9 Y
4 51 B Lump Y N Left 0.6 28.2 2.5 1.6 Y
5 79 W Lump Y Y Right 3.0 29.6 8.2 8.5 N
6 46 W Lump Y Y Left 3.4 30.6 5.9 4.6 N
7 54 B Mast N Y Left 2.3 29.5 8.3 7.8 N
8 54 W Mast Y Y Left 1.9 32.4 3.1 3.0 N
9 41 W Mast Y Y Left 1.4 30.0 6.6 5.8 N
All of the patients had axillary lymph node dissection.
A, Asian/far Eastern/Indian subcontinent; Baseline and Post-Tx difference, difference between affected and unaffected arm; B, Black/African American; 
BMI, body mass index; Chemo, history of chemotherapy; Dx, diagnosis; Lump, lumpectomy; Mast, mastectomy; RT, history of radiation therapy; W, white.
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ranged in age from 41 to 79 years, with a median age 
of 54 years. The average difference in affected versus 
unaffected arm circumference at accrual was 4.5 cm (SD 
2.7   cm). All patients were breast cancer survivors with 
upper extremity lymphoedema; all had axillary lymph 
node dissection.
This pilot study met its goal after nine subjects were 
treated: four women showed at least a 30% reduction in 
the extent of lymphoedema at 4 weeks when compared 
with their respective baseline values. In 73 treatment ses-
sions, no SAE occurred and no SAE occurred during the 
6-month follow-up period. Some patients experienced 
minor toxicities such as slight bruising or minor pain at 
the acupuncture site shortly after treatment.
There were no obvious differences between responders 
and non-responders with respect to age, ethnicity, type of 
surgery, adjuvant therapy or duration of lymphoedema. 
Additional details are provided in Table 2, for all the nine 
study patients.
DISCUSSION
We saw no evidence to the effect that acupuncture for lym-
phoedema is unsafe. The response rate met our predeﬁ  ned 
criterion for considering acupuncture worthy of further 
study. These positive results led to our development of 
a randomised clinical trial to evaluate the effects of acu-
puncture on chronic lymphoedema due to breast cancer 
surgery. The aetiology of lymphoedema, including why it 
develops in some patients but not in others who received 
identical treatment, remains unknown. Therefore, we 
will also conduct laboratory studies of mechanisms that 
regulate lymphoedema. Hopefully, these studies will shed 
light on the mechanisms by which acupuncture serves to 
improve it.
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Summary points
▶  Acupuncture is contraindicated in limbs with lymphoedema
▶  However it may be useful and the evidence on safety is inconclusive
▶  In this pilot study, we found four responders in nine patients and no 
adverse events
▶  Larger studies are needed
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